Work Experience
2000–2003
Ophthalmology Residency Ophthalmology Department General Hospital "Sveti Duh", Zagreb (Croatia)
2004–2010
Ophthalmology Specialist at Retina Department, University Eye Hospital Svjetlost, Zagreb (Croatia)
2010–Present
Retina Department Head
University Eye Hospital Svjetlost, Zagreb (Croatia)
2013–Present
Consultant Vitreo-Retinal Surgeon
University Eye Hospital Svjetlost, Zagreb (Croatia)
Education and Training
1999–2000
School of Medicine, University of Zagreb, Zagreb (Croatia)
2000–2001
Research Fellow at scientific project "Corneal Transplantation - Eye Bank" Ophtahlmology Department General Hospital " Sveti Duh", Zagreb (Croatia)
2001–2005
Ophthalmology Residency General Hospital "Sveti Duh" and University Eye Hospital "Svjetlost", Zagreb (Croatia)
2002–2004
Postgraduate Fellowship "Physiology and Imunobiology
Department for Biology, School of Science, University of Zagreb, Zagreb (Croatia)
2008
Masters Degree in Science
School of Science, University of Zagreb, Zagreb (Croatia)
2010
PhD degree,School of Medicine, University of Rijeka, Rijeka (Croatia)
2011
Research Assistant Degree, School of Medicine, University of Rijeka
2000-2013
Fellowship in Vitreoretinal surgery with Dr.Zoran Tomic Head of Vitreoretinal Department University Hospital, Uppsala ,Sweden
2014
Assistant Professor in Ophthalmology, School of Medicine, University of Rijeka, Rijeka (Croatia)
Job-related skills
Surgical skills: minimally invasive vitrectomy (23 gauge,5000 cpm) in retinal detachment (silicone oil or gas tamponade), complex retinal detachemnt with PVR, in diabetic retinopathy with tractional retinal detachment or proliferative diabetic retinopathy, macular diseases (macular pucker, VMT and macular hole), eye injury and removal of intraocular foreign bodies, uveitis and endophthalmitis surgery. Combined cataract and vitrectomy surgery. Phacoemulsification cataract surgery with standard, multifocal and toric intraocular lenses implantation. Iris-claw lenses and phakic lCL lenses implantation. Scleral tunnel IOLs fixation. Number of vitrectomies approx 2000. Number of cataract surgeries approx 6000.
Implementation of new therapeutic methods: verteporfin photodynamic therapy in age-related macular degeneration (2004.), therapy for the posterior eye segment diseases (macular degeneration, diabetic macular edema, retinal vascular diseases) with intravitreal injections (triamcinolon 2004., bevacizumab 2005., ranibizumab 2007., dexamethasone intravitreal implants 2011, aflibercept 2013.Implementation of new diagnostic methods: Digital Fluorescein Angiography (2003.), Optical Coherent Tomopgraphy (2005.)Active in publishing peer reviewed papers 14 CC indexed manuscripts (including Graefe Archives 2006, Ophthalmology 2007, Retina 2013). Investigator in various multicultural randomized studies in development of new retinal drugs (2016 Fovista)
Communication skills
Highly experienced in presenting and discussion. Experienced in team work.Experienced in mentor-ship for research fellows, ophthalmology residents and fellows in medical and surgical retina
Organisational / managerial skills
Experienced in leadership. Experienced in organizing international scientific meetings. Active in implementation of new diagnostic and therapeutic procedures in medical and surgical retina.
Currently Head of Retina Department in Universitiy Eye Hospital supervising 7 doctors and 15 nurses and 6 other stuff.
Memberships
American Society of Retina Specialists member since 2005
Conferences Annually attending American Society of Retina Specialists meetings since 2005 (Palm Spring, Hawaii, New York, Boston, Toronto, San Diego
Major Publications
- Treatmentof anti-vascular endothelial growth factor-resistant diabetic macular edemawith dexamethasone intravitreal implant; LAZIC R, Lukic M., Boras I., Draca N.,Vlasic M., Gabric N., Tomic Z. ; Retina 2013, Aug 22.
- Potencial beneficial role of sevelamer hydrochloride in diabetic retinopathy;Draca N., LAZIC R, Simic P., Dumic-Cule I., Luetic AT,Gabric N.; Med Hypotheses2013 Apr;80(4):431-5.
- Anti-VEGF in treatment of diabetic macular edema; Boras I., LAZIC R, GabrićN.,Lukić M., Dekaris I.; Collegium Antroplogicum. 35(Suppl2):15-8,2011Sep
- AntiVEGF in Treatment of Central Retinal Vein Occlusion; LAZIC R, Boras I., VlasicM., Gabric N., Tomic Z.; Collegium Antropologicum.34(Suppl2):69-72,2010 Apr.
- Comparison of Diffractive and Refractive Multifocal Intraocular Lenses in PresbyopiaTreatment; Barišić A., Dekaris I., Gabric N., Bohac M., Romac I., MravicicI., LAZIC R ; CollegiumAntropologicum.32(Suppl2):27-31,2008 Oct.
- Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularizationdue to age –related macular degneration; LAZIC R, Gabric N.;Ophthalmology.114(6):1179-1185, 2007 Jun.
- Blue light filtering intaraocular lenses in phacoemulsification cataract surgery; BarišićA., Dekaris I., Gabric N., Bosnar D., LAZIC R, Martinović ZK, Krstonijević EK, ; Collegium Antropologicum.31(Suppl1):57-60,2007 Jan.
- Photodynamic therapy combined with intravitreal bevacizumab (Avastin) in treatment withchoroidal neovascularization secondary to age related macular degeneration;LAZIC R, Gabric N.; Dekaris I., Gavric M., Bosnar D Collegium Antropologicum.31(Suppl1):71-75,2007 Jan.
- Intravitreal bevacizumab (Avastin) in tretment of neovascular age related maculardegneration; LAZIC R, Gabric N.; Dekaris I., Šarić B, Gavric M.; CollegiumAntropologicum. 31(Suppl1):77-87,2007 Jan.
- Intravitreally administered bevacizumab (Avastin) in a minimally classic and occult choroidalneovascularization secondary to age related macular degneration; LAZIC R,Gabric N.; Graefes Archive for Clinical and Experimental Opthalmology 245(Suppl1):68-73, 2007 Jan.
- Influence of interleukin-1 alpha and tumor necrosis factor – alpha production on cornealgraft survival; Bosnar D., Dekaris I. Gabric N., Markotic A., LAZIC R.,Spoljaric N.; Croatian Medical Journal 47( Suppl 1): 59-66, 2006 Feb.
- IL -1 alphaproduction in human corneal scars; Dekaris I., Gabric N., Bosnar D., Gagro A.,Markotic A., LAZIC R.; Collegium Antropologicum. 29(Suppl1):81-84,2005.
- Gastricpentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats;LAZIC R., Gabric N., Dekaris I., Bosnar D., Boban – Blagaic A., Sikiric P.;Collegium Antropologicum. 29(Suppl1):321-325,2005 Jun.
- Multylayer vs.monolayer amniotic membrane transplantation for deep corneal ulcer treatment;Dekaris I., Gabric N., Mravicic I., Karaman Z., Katusic J., LAZIC R., SpoljaricN.; Collegium Antropologicum. 25(Suppl5):23-28,2001 Jun.
